Janus Henderson Group
SAGE

Janus Henderson Group’s Sage Therapeutics SAGE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,893
Closed -$140K 2538
2024
Q4
$140K Hold
25,893
﹤0.01% 2490
2024
Q3
$187K Hold
25,893
﹤0.01% 2447
2024
Q2
$281K Sell
25,893
-266
-1% -$2.89K ﹤0.01% 2237
2024
Q1
$490K Hold
26,159
﹤0.01% 2016
2023
Q4
$567K Sell
26,159
-40
-0.2% -$866 ﹤0.01% 1931
2023
Q3
$539K Buy
26,199
+4
+0% +$82 ﹤0.01% 1884
2023
Q2
$1.23M Sell
26,195
-392,551
-94% -$18.5M ﹤0.01% 1500
2023
Q1
$17.6M Sell
418,746
-200,544
-32% -$8.41M 0.01% 600
2022
Q4
$23.6M Sell
619,290
-843,556
-58% -$32.2M 0.02% 534
2022
Q3
$57.3M Buy
1,462,846
+695,797
+91% +$27.2M 0.02% 485
2022
Q2
$24.8M Sell
767,049
-262,904
-26% -$8.49M 0.02% 523
2022
Q1
$34.1M Buy
1,029,953
+54,971
+6% +$1.82M 0.02% 606
2021
Q4
$41.5M Sell
974,982
-76,011
-7% -$3.23M 0.02% 606
2021
Q3
$46.6M Sell
1,050,993
-609,460
-37% -$27M 0.02% 573
2021
Q2
$94.3M Sell
1,660,453
-212,929
-11% -$12.1M 0.04% 386
2021
Q1
$140M Sell
1,873,382
-105,429
-5% -$7.89M 0.06% 293
2020
Q4
$171M Buy
1,978,811
+359,110
+22% +$31.1M 0.08% 252
2020
Q3
$99M Buy
1,619,701
+160,025
+11% +$9.78M 0.05% 330
2020
Q2
$60.7M Buy
1,459,676
+71,881
+5% +$2.99M 0.03% 442
2020
Q1
$39.9M Sell
1,387,795
-1,026,417
-43% -$29.5M 0.03% 514
2019
Q4
$174M Buy
2,414,212
+398,808
+20% +$28.8M 0.09% 250
2019
Q3
$283M Buy
2,015,404
+141,996
+8% +$19.9M 0.15% 161
2019
Q2
$343M Buy
1,873,408
+204,779
+12% +$37.5M 0.19% 135
2019
Q1
$265M Buy
1,668,629
+1,359,947
+441% +$216M 0.15% 173
2018
Q4
$29.6M Buy
308,682
+44,019
+17% +$4.22M 0.02% 654
2018
Q3
$37.4M Buy
264,663
+87,427
+49% +$12.3M 0.02% 659
2018
Q2
$27.7M Sell
177,236
-7,413
-4% -$1.16M 0.02% 717
2018
Q1
$29.7M Sell
184,649
-12,386
-6% -$1.99M 0.02% 693
2017
Q4
$32.5M Buy
+197,035
New +$32.5M 0.02% 645